Skip to main content
Clinical Trials/NCT06686940
NCT06686940
Not yet recruiting
Not Applicable

Photoplethysmography (PPG) Algorithm With Smartwatch in Evaluation of Atrial Fibrillation Burden

Beijing Anzhen Hospital1 site in 1 country10,000 target enrollmentDecember 30, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation (AF)
Sponsor
Beijing Anzhen Hospital
Enrollment
10000
Locations
1
Primary Endpoint
Primary outcome
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to evaluate the monitoring effect of a smart electrocardiogram watch based on the PPG algorithm on atrial fibrillation burden.

Registry
clinicaltrials.gov
Start Date
December 30, 2024
End Date
December 30, 2034
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Beijing Anzhen Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Atrial fibrillation patients diagnosed by electrocardiogram
  • Willing to use long-range electrocardiogram monitoring equipment

Exclusion Criteria

  • 1.Patients who are allergic to electronic devices or unable to wear watches

Outcomes

Primary Outcomes

Primary outcome

Time Frame: December 30, 2024 to Decemberr 30, 2034

all-cause death, cardiovascular death, myocardial infarction, heart failure, stroke, peripheral vascular disease, recurrence of atrial fibrillation diagnosed by electrocardiogram, palpitations symptoms

Study Sites (1)

Loading locations...

Similar Trials